L R Bisset|W Fierz - JoVE Visualize

Showing results (51-60 of 63) with videos related to

Pageof 7

Sort By:

AIDS (London, England)|March 15, 1997

Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavirL R Bisset, M Rothen, H I Joller-Jemelka, et al.

Deutsche Medizinische Wochenschrift (1946)|June 30, 1989

[The natural history and laboratory parameters of HIV infection]J Brühwiler, R Lüthy, H I Joller-Jemelka, et al.

Journal of Neuroimmunology|May 15, 2007

Expert opinion: guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapiesR Gold, A Jawad, D H Miller, et al.

Annals of Neurology|March 1, 1990

The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous systemH P Hartung, B Schäfer, P H van der Meide, et al.

AIDS (London, England)|December 2, 1998

Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort StudyL R Bisset, R W Cone, W Huber, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 17, 1998

Serological evidence of human granulocytic ehrlichiosis in SwitzerlandN Pusterla, R Weber, C Wolfensberger, et al.

Allergy|March 26, 2003

Altered intracellular expression of the chemokines MIP-1alpha, MIP-1beta and IL-8 by peripheral blood CD4+ and CD8+ T cells in mild allergic asthmaM Grob, P Schmid-Grendelmeier, H I Joller-Jemelka, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|July 21, 2001

Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infectionL R Bisset, R W Cone, M Fischer, et al.

AIDS Research and Human Retroviruses|August 24, 2000

Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapyM Fischer, H F Günthard, M Opravil, et al.

Annals of Neurology|January 1, 1988

Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter studyL Kappos, U Patzold, D Dommasch, et al.

Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:

Pageof 7

AIDS (London, England)|March 15, 1997

Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavirL R Bisset, M Rothen, H I Joller-Jemelka, et al.

Deutsche Medizinische Wochenschrift (1946)|June 30, 1989

[The natural history and laboratory parameters of HIV infection]J Brühwiler, R Lüthy, H I Joller-Jemelka, et al.

Journal of Neuroimmunology|May 15, 2007

Expert opinion: guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapiesR Gold, A Jawad, D H Miller, et al.

Annals of Neurology|March 1, 1990

The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous systemH P Hartung, B Schäfer, P H van der Meide, et al.

AIDS (London, England)|December 2, 1998

Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort StudyL R Bisset, R W Cone, W Huber, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 17, 1998

Serological evidence of human granulocytic ehrlichiosis in SwitzerlandN Pusterla, R Weber, C Wolfensberger, et al.

Allergy|March 26, 2003

Altered intracellular expression of the chemokines MIP-1alpha, MIP-1beta and IL-8 by peripheral blood CD4+ and CD8+ T cells in mild allergic asthmaM Grob, P Schmid-Grendelmeier, H I Joller-Jemelka, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|July 21, 2001

Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infectionL R Bisset, R W Cone, M Fischer, et al.

AIDS Research and Human Retroviruses|August 24, 2000

Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapyM Fischer, H F Günthard, M Opravil, et al.

Annals of Neurology|January 1, 1988

Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter studyL Kappos, U Patzold, D Dommasch, et al.

Pageof 7